Influence of migration on characteristics of type 2 diabetes in sub-Saharan Africans

Diabetes and Metabolism

Volumn 40, Issue 1, 2014, Pages 56-60

  Choukem, S P ^a,b   Fabreguettes, C ^a   Akwo, E ^c   Porcher, R ^d   Nguewa, J L ^a   Bouche, C ^a   Kaze, F F ^e   Kengne, A P ^f,g   Vexiau, P ^a   Mbanya, J C ^c,e   Sobngwi, E ^c,e   Gautier, J F ^a,h  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITY OF BUEA   (Cameroon)

^c YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^f SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^g UNIVERSITY OF SYDNEY   (Australia)

^h CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Africans; Caucasians; Complications; Migration; Type 2 diabetes

Indexed keywords

AFRICANS; CAUCASIANS; COMPLICATIONS; MIGRATION; TYPE 2 DIABETES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAMEROON; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; EMIGRANTS AND IMMIGRANTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF HEALTH CARE;

EID: 84893810671     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.07.004     Document Type: Article

References (21)

1. American Diabetes Association Standards of medical care in diabetes-2007. Diabetes Care 2007, 30(Suppl. 1):S4-S41.
2. Brancati F.L., Kao W.H., Folsom A.R., Watson R.L., Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000, 283:2253-2259.
3. Koopman R.J., Mainous A.G., Diaz V.A., Geesey M.E. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med 2005, 3:60-63.
4. Mbanya J.C., Cruickshank J.K., Forrester T., Balkau B., Ngogang J.Y., Riste L., et al. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care 1999, 22:434-440.
5. Cooper R.S., Rotimi C.N., Kaufman J.S., Owoaje E.E., Fraser H., Forrester T., et al. Prevalence of NIDDM among populations of the African diaspora. Diabetes Care 1997, 20:343-348.
6. Poulter N.R., Khaw K.T., Hopwood B.E., Mugambi M., Peart W.S., Rose G., et al. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ 1990, 300:967-972.
7. Yusuf S., Reddy S., Ounpuu S., Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001, 104:2746-2753.
8. Osei K., Cottrell D.A., Adenuwon C.A., Ezenwaka E.C., Akanji A.O., O'Dorisio T.M. Serum insulin and glucose concentrations in people at risk for type II diabetes. A comparative study of African Americans and Nigerians. Diabetes Care 1993, 16:1367-1375.
9. Osei K., Schuster D.P. Metabolic characteristics of African descendants: a comparative study of African-Americans and Ghanaian immigrants using minimal model analysis. Diabetologia 1995, 38:1103-1109.
10. Mauvais-Jarvis F., Sobngwi E., Porcher R., Riveline J.P., Kevorkian J.P., Vaisse C., et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004, 53:645-653.
11. Sobngwi E., Choukem S.P., Agbalika F., Blondeau B., Fetita L.S., Lebbe C., et al. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in Sub-Saharan Africans. JAMA 2008, 299:2770-2776.
12. Sobngwi E., Gautier J.F., Kevorkian J.P., Villette J.M., Riveline J.P., Zhang S., et al. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. J Clin Endocrinol Metab 2005, 90:4446-4451.
13. Sobngwi E., Mauvais-Jarvis F., Vexiau P., Mbanya J.C., Gautier J.F. Diabetes in Africans. Part 2: ketosis-prone atypical diabetes mellitus. Diabetes Metab 2002, 28:5-12.
14. Choukem S.P., Kengne A.P., Dehayem Y.M., Simo N.L., Mbanya J.C. Hypertension in people with diabetes in Sub-Saharan Africa: revealing the hidden face of the iceberg. Diabetes Res Clin Pract 2007, 77:293-299.
15. Alberti K., Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: daignosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
16. Williams B., Poulter N.R., Brown M.J., Davis M., McInnes G.T., Potter J.F. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV). BMJ 2004, 328:634-640.
17. Sobngwi E., Mbanya J.C., Unwin N.C., Porcher R., Kengne A.P., Fezeu L., et al. Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. Int J Epidemiol 2004, 33:769-776.
18. Harris M.I., Klein R., Welborn T.A., Knuiman M.W. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992, 15:815-819.
19. Van Velthuysen M.L. Glomerulopathy associated with parasitic infections. Parasitol Today 1996, 12:102-107.
20. Muramatsu T., Hora K., Ako S., Tachibana N., Hora K., Tanaka E. The role of hepatitis C virus infection in glomerulopathy. Hepatol Res 2000, 18:190-202.
21. D'Agati V., Appel G.B. HIV infection and the kidney. J Am Soc Nephrol 1997, 8:138-152.